Navigation Links
Daily aspirin may reduce risk of common type of breast cancer
Date:4/30/2008

Taking aspirin on a daily basis may lower womens risk of a particular type of breast cancer, according to results published in BioMed Centrals open access journal Breast Cancer Research. In this large study, aspirin use was linked to a small reduction in estrogen receptor-positive breast cancers. However, unlike in some previous research, aspirin and related painkillers were not found to reduce the total risk of breast cancer.

Around 75% of breast cancers are estrogen receptor-positive (ER+), which means the cancer cells have receptors for the female hormone estrogen on their surface. Estrogen helps the cancer cells grow, so drugs that block the action of estrogen are often used to treat ER+ cancer.

It is feasible, in theory, that aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) could lower the total risk of breast cancer. They block an enzyme called cyclooxygenase, an activity that could disrupt breast cancer development in a number of ways for example, by reducing the amount of estrogen produced in the body.

A US research team, led by Gretchen Gierach, studied over 127,000 women enrolled in the National Institutes of HealthAARP Diet and Health Study, which was designed to explore the possible links between diet, health-related behaviours and cancer in older people in the USA. For the current research, the participants were women aged 5172 with no history of cancer.

Unlike other NSAIDs, aspirin has irreversible effects on cyclooxygenase (COX) enzymes, so the study authors looked for differences in cancer development according to whether women used aspirin or another kind of NSAID.

NSAID use was not linked to total risk of breast cancer in this study. However, when the team considered different cancer subtypes and specific types of NSAIDs, they found that daily aspirin use was associated with a small reduction (16%) in the risk of ER+ breast cancer. A similar link was not seen in cases of ER- breas
'/>"/>

Contact: Charlotte Webber
charlotte.webber@biomedcentral.com
44-020-763-19980
BioMed Central
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Smiles. Made Fresh Daily
2. FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
3. Labopharm Appeals FDAs Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy
4. Once-Daily Insulin Shot Proves Effective in Study
5. U.S. Census Bureau Daily Feature for March 15
6. Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
7. U.S. Census Bureau Black History Month Daily Feature for February 27
8. A Once-Daily Oral Drug for Chronic Obstructive Pulmonary Disease That Treats COPD-Related Inflammation Could Achieve Blockbuster Status
9. HIV Drug in Microbicide Gel Safe for Daily Use
10. Trial finds tenofovir gel safe for daily use and most women adhered to study regimens
11. Daily Stress May Raise Womens Risk of Cervical Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...-back, chest-out position promotes self-assurance,...thDay News) -- Your mother may have been right whe...ggests that good posture could make you feel more ...ere taught that sitting up straight gives a good i...or of the study and a psychology professor at Ohio...
(Date:11/8/2009)...SHINGTON, Nov. 7 Tonigh...le Health Care for America Act, landmark health re...as access to quality, affordable, stable and secur...cks down on some of the insurance industry,s worst...ericans and cut the deficit by $104 billion over t...
(Date:11/8/2009)... A jury of 8 people in the Wester...woman $2,300,000 in pain and suffering for a medic...mes Tallman and Alicia Nocera of Thomas E. Crenney... the plaintiff, Vita Monestersky and against the U...ency total abdominal hysterectomy at age 18. , ...
(Date:11/8/2009)...SHINGTON, Nov. 8 Pharma...RMA) Senior Vice President Ken Johnson released th...are reform bill: ,, "We are disappointed, but n...ed by millions of hardworking Americans as well as...epresentatives who voted against the bill. ,, "...
(Date:11/8/2009)...ARP Praises House Passage of Health Care Reform Bi...edicare, improve coverage for all Americans ,,...MARY: Tonight the United States House of Represen...tion that would strengthen Medicare for seniors an...rices millions of Americans out of affordable heal...
Breaking Medicine News(10 mins):Health News:Good Posture May Inspire Confidence 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3
...n ability to eliminate disease by 2010 , ,...ing for the elimination of measles in Europe by 2...ccination rates in five countries where outbreaks ...occurred in Germany, Italy, Romania, Switzerland a...
...he 13th with Breakout Session to Follow , , ...TC Bulletin Board: NWCI) a cardiac diagnostic and ...ajdic, the Company,s Chief Executive Officer, and ... the Sir Francis Drake Hotel. NewCardio,s presenta...
...rporation ("AGA,Medical") announced today that it ...alth, Labour and Welfare (MHLW) for its AMPLATZER(... transcatheter occlusion device used for the,non-s...osus fails to close after birth, as it normally sh...
...andard Adjunctive Treatment for Partial-Onset Epil...ion Resources , , WALTHAM, Mass., Jan. 7 Decisio...nd advisory firms focusing on pharmaceutical and h...U.S. neurologists, a drug of this type would earn ...
...rt to improve awareness and knowledge of Daiichi S...., Jan. 7 Daiichi Sankyo, Inc., announced today t...kyo de Puerto Rico, Inc. Daiichi Sankyo de Puerto...l sales and marketing. Vazquez, who earned his Bac...
...nces Enthusiastic Adoption Across 40 Specialties i...MedAptus(R), market leader for charge capture tech...rvices Foundation, Inc. (KMSF) has successfully im... means that a successful replacement of the organi...
Other Medicine News:Health News:Europe Unlikely to Meet Measles Goals: Report 2Health News:NewCardio to Present at OneMedForum 2009: Disrupters and Drivers on January 13 in San Francisco 2Health News:NewCardio to Present at OneMedForum 2009: Disrupters and Drivers on January 13 in San Francisco 3Health News:NewCardio to Present at OneMedForum 2009: Disrupters and Drivers on January 13 in San Francisco 4Health News:AGA Medical Receives Japanese Approval for AMPLATZER(R) Duct Occluder 2Health News:AGA Medical Receives Japanese Approval for AMPLATZER(R) Duct Occluder 3Health News:Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily 2Health News:Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily 3Health News:Daiichi Sankyo, Inc. Establishes Subsidiary in Puerto Rico 2Health News:Kentucky Medical Services Foundation Completes Successful Charge Capture Technology Conversion 2Health News:Kentucky Medical Services Foundation Completes Successful Charge Capture Technology Conversion 3
(Date:11/7/2009)...7 Most patients with hereditary an... an oncoming HAE attack giving the patients suffic...orbidity associated with that attack, according to...can College of Allergy, Asthma & Immunology (A...s such as fatigue and nausea, which occur frequent...
(Date:11/6/2009)...swire-FirstCall/ -- Recession in domestic and inte...llied Healthcare Products in the first quarter of ...Sales declines pushed Allied into a loss for the q...45,000, or negative 9 cents per share, compared to...or 3 cents per share. ,, Sales fell about 21 p...
(Date:11/6/2009)...swire/ -- Trius Therapeutics, Inc. announced today...m S-1 with the U.S. Securities and Exchange Commis...ffering of shares of its common stock. All shares ...l be offered by the Company. ,, Credit Suisse S... manager, Piper Jaffray & Co. is acting as co-...
Breaking Medicine Technology:Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Reportlinker Adds 2008 2009 Healthcare Research Review Report 56185 1Reportlinker Adds 2008 2009 Healthcare Research Review Report 56185 2Reportlinker Adds 2008 2009 Healthcare Research Review Report 56185 3Reportlinker Adds 2008 2009 Healthcare Research Review Report 56185 4Reportlinker Adds 2008 2009 Healthcare Research Review Report 56185 5Reportlinker Adds 2008 2009 Healthcare Research Review Report 56185 6Reportlinker Adds 2008 2009 Healthcare Research Review Report 56185 7Reportlinker Adds 2008 2009 Healthcare Research Review Report 56185 8Reportlinker Adds 2008 2009 Healthcare Research Review Report 56185 9Reportlinker Adds 2008 2009 Healthcare Research Review Report 56185 10Reportlinker Adds 2008 2009 Healthcare Research Review Report 56185 11Reportlinker Adds 2008 2009 Healthcare Research Review Report 56185 12Reportlinker Adds Botanical and Plant Derived Drugs 3A Global Markets Report 56183 1Reportlinker Adds Botanical and Plant Derived Drugs 3A Global Markets Report 56183 2Reportlinker Adds Botanical and Plant Derived Drugs 3A Global Markets Report 56183 3Reportlinker Adds Botanical and Plant Derived Drugs 3A Global Markets Report 56183 4Reportlinker Adds Membrane 26 Separation Technology News Review 2008 Report 56180 1Reportlinker Adds Membrane 26 Separation Technology News Review 2008 Report 56180 2Reportlinker Adds Membrane 26 Separation Technology News Review 2008 Report 56180 3
...tment for inhalation anthrax - , , ROCKVILLE, Md....GSI ) today announced that it has submitted a Biol...nd Drug Administration (FDA) for its human monoclo...e treatment of inhalation anthrax. , , (Logo: ...LOGO ) , , The BLA submission includes the re...
...Newswire/ -- Ridge Diagnostics, Inc., a neurodia... studies for its first-in-class, proprietary blood...presented during a poster session entitled Multia...reatment and Management of Major Depressive Disord...l Meeting, May 20, 2009. , , The blood test, for...
Other Medicine Technology:Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM) 2Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM) 3Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM) 4Ridge Diagnostics, Inc. Clinical Data on Blood Test for Depression Presented at American Psychiatric Association Annual Meeting 2
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: